While the start of 2022 brought uncertainty in the orthopedics space due to a drop off in the demand as facilities canceled or delayed elective procedures, the sector has since made significant strides, MD+DI reports. M&A and development of new technologies has led activities in orthopedics. M&As remained an active strategy in 2022, with differing deal structures. The year’s major deals included an acquisition of CrossRoads Extremity Systems by Depuy Synthes, adding to the latter’s foot and ankle surgery portfolio. Read more.
Related Posts
Oregon Launches Merger Oversight Program as Hospitals Object
Because the program focuses exclusively on big transactions, hospital deals would likely be most affected
March 10, 2022
LRVHealth Raises $200 Million Fund V
LRVHealth said 90% of its strategic limited partners are actively engaged with at least one of the firm’s portfolio companies.
May 18, 2023
4 Trends Driving Platform Adoption in Health Care
The industry’s journey to technology adoption has been 25 years in the making.
August 5, 2022
Will Waystar Kick off Another Wave of Digital Health IPOs?
“The one company that we know is going to IPO and everyone's looking at is Waystar,” said Sofia Guerra, vice president at venture capital firm Bessemer Venture Partners. “Everyone's kind of waiting to see how that's going to go.”
October 20, 2023